Treating low-risk febrile neutropenia: Jenny's story

Archives of Disease in Childhood

Volumn 92, Issue 1, 2007, Pages 7-8

  Phillips, R ^a   Skinner, R ^b   Chisholm, J C ^c  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CIPROFLOXACIN; CISPLATIN; DOXORUBICIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; BACTERIAL INFECTION; BODY TEMPERATURE; CASE REPORT; CHILDHOOD MORTALITY; CLINICAL TRIAL; DRUG ABSORPTION; DRUG SAFETY; FEBRILE NEUTROPENIA; FEMALE; HEALTH CARE COST; HEPATOBLASTOMA; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; MONOTHERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEPSIS; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CHILD, PRESCHOOL; DELIVERY OF HEALTH CARE; FEMALE; FEVER; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; NEUTROPENIA;

EID: 33846359388     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.095521     Document Type: Review

References (19)

1. Orudjev E, Lange BJ. Evolving concepts of management of febrile neutropenia in children with cancer. Med Pediatr Oncol 2002;39:77-85.
2. Viscoli C, EORTC International Antimicrobial Therapy Group. Management of infection in cancer patients. Studies of the EORTC International Antimicrobial Therapy Group (IATG). Eur J Cancer 2002;38(Suppl 4):S82-7.
3. Hann I, Viscoli C, Paesmans M, et al. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol 1997;99:580-8.
4. Klastersky J, Paesmans M, Rubenstein EB, et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000;18:3038-51.
5. Talcott JA, Siegel RD, Finberg R, et al. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol 1992;10:316-22
6. Madsen K, Rosenman M, Hui S, et al. Value of electronic data for model validation and refinement: bacteremia risk in children with fever and neutropenia. J Pediatr Hematol Oncol 2002;24:256-62.
7. Klaassen RJ, Goodman TR, Pham B, et al. "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol 2000;18:1012-19.
8. Santolaya ME, Alvarez AM, Becker A, et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol 2001;19:3415-21.
9. Nijhuis CO, Kamps WA, Daenen SM, et al. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients. J Clin Oncol 2005;23:7437-44.
10. Santolaya ME, Alvarez AM, Aviles CL, et al. Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection. J Clin Oncol 2004;22:3784-9.
11. Paganini H, Gomez S, Ruvinsky S, et al. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina. Cancer 2003;97:1775-80.
12. Shenep JL, Flynn PM, Baker DK, et al. Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer. Clin Infect Dis 2003;32:36-43.
13. Dommett R, Sharland M, Freeman S, et al. Prospective audit of a low risk management strategy in febrile neutropenia (FN): a Thames Paediatric Oncology Centre (TPOC) study. Pediatr Blood Cancer 2005;45:418.
14. Quezada G, Sunderland T, Chan KW, et al. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer. Pediatr Blood Cancer 2006;24:Epub ahead of print.
15. Mullen CA, Petropoulos D, Roberts WM, et al. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Cancer 1999;86:126-34.
16. Vidal L, Paul M, Ben-Dor I, et al. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials. J Antimicrob Chemother 2004;54:29-37.
17. Petrilli AS, Dantas LS, Campos MC, et al. Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial, Med Pediatr Oncol 2000;34:87-91.
18. Malik IA. Out-patient management of febrile neutropenia in indigent paediatric patients. Ann Acad Med Singapore 1997;26:742- 6.
19. Phillips R, Phelan L, Picton S. An audit of the use of oral antibiotics and early discharge in the treatment of low risk febrile neutropenia in children. Arch Dis Child 2006;91:A80-2.